Synthesis and anticancer activities of amphiphilic 5-fluoro-2′-deoxyuridylic acid prodrugs
作者:Peter S. Ludwig、Reto A. Schwendener、Herbert Schott
DOI:10.1016/j.ejmech.2004.12.006
日期:2005.5
lyl-(3' --> 5')-3'-O-acetyl-5-fluoro-2'-deoxyuridine (dC(pam)-5-FdU(Ac), N4-palmitoyl-2',3'-dideoxycytidylyl-(5' --> 5')-3'-O-acetyl-5-fluoro-2'-deoxyuridine (ddC(pam)-(5' --> 5')-5-FdU(Ac), 5-fluoro-2'-deoxyuridylyl-(3' --> 5')-5-fluoro-N4-hexadecyl-2'-deoxycytidine (5-FdU-5-FdC(hex)), and of the new liponucleotide 1-O-octadecyl-rac-glycerylyl-(3 --> 5')-5-fluoro-2'-deoxyuridine (Oct1Gro-(3 --> 5')-5-FdU)
5'-氟-2'-脱氧尿苷-5'-单磷酸酯(5-FdUMP)的两亲抗癌前药是通过将亲脂性胞嘧啶衍生物或磷脂与5-氟-2'-脱氧尿苷偶联的氢膦酸盐方法合成的(5 -FdU)。美国国家癌症研究所体外抗癌筛选计划内的研究表明,异二核苷磷酸酯具有很高的抗癌活性:N4-棕榈酰基-2'-脱氧胞嘧啶-(3'-> 5')-3'-O-乙酰基-5 -氟-2'-脱氧尿苷(dC(pam)-5-FdU(Ac),N4-棕榈酰基-2',3'-二脱氧胞嘧啶-(5'-> 5')-3'-O-乙酰基-5 -氟-2'-脱氧尿苷(ddC(pam)-(5'-> 5')-5-FdU(Ac),5-氟-2'-脱氧尿苷-(3'-> 5')-5 -氟-N4-十六烷基-2'-脱氧胞苷(5-FdU-5-FdC(hex)),以及新的脂核苷酸1-O-十八烷基-rac-甘油基-(3-> 5')-5-氟-2'-脱氧尿苷(Oct1Gro-(3-> 5')-5